Allstate Corporation’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$651K Sell
9,873
-7,016
-42% -$535K 0.01% 724
2026
Q2
$1.44M Sell
16,889
-4,601
-21% -$330K 0.01% 611
2026
Q1
$1.42M Buy
+21,490
New +$1.37M 0.02% 666

Other funds holding CYTK

Allstate Corporation's CYTK Position: Q3 2026 in Review

Allstate Corporation reduced its Cytokinetics (CYTK) stake by 42% in Q3 2026, selling an estimated $535K and leaving 9,873 shares worth $651K. The position accounts for 0.01% of the portfolio, ranked #724.

Allstate Corporation first reported a position in CYTK in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.44M in Q2 2026. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Allstate Corporation held 9,873 shares of Cytokinetics worth $651K as of Q3 2026.
  • Allstate Corporation sold 7,016 Cytokinetics shares in Q3 2026, an estimated $535K.
  • Cytokinetics made up 0.01% of Allstate Corporation's portfolio in Q3 2026, its #724 holding.
  • Allstate Corporation first reported a position in Cytokinetics in Q1 2026 and has held it in 3 quarters since.
  • Allstate Corporation's Cytokinetics position peaked at $1.44M in Q2 2026.
  • 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Allstate Corporation's 13F filing for Q3 2026, filed 16 Nov 2026.